BioCatalyst

EWTX — Edgewise Therapeutics, Inc. catalysts

1 verified catalyst event(s) for Edgewise Therapeutics, Inc. (ticker EWTX). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-09-01 — Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON) · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-09 (month)
in 2mo
ESTIMATED
 READOUT
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Phase 2 · Becker Muscular Dystrophy
 EWTX Edgewise Therapeutics, Inc. Sevasemten 10 mg, Sevasemten 5 mg, Sevas ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.